*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Benefits Of Low Molecular Weight Heparin

Author: , M.ASHRITHA, LAKSHMINARAYANAN ARIVARASU, JAYALAKSHMI SOMASUNDARAM
Abstract: Low molecular weight heparin belongs to the class of antithrombotic agents. They are smaller fragments with larger mucopolysaccharide which is derived from unfractionated heparin. It enhances the antithrombin property and thereby produces antithrombin by inhibiting factor Xa. it reduces the incidence of deep vein thrombosis in patients with placebo. The mode of action is somewhat different from the conventional heparin. It could be used Xa. It reduces the incidence of deep vein thrombosis in patients with placebo. It could be used in the treatment of DVT prophylaxis, venous thromboembolism in pregnancy, unstable angina, prevention of clotting in extracorporeal circuits. Its main use is in the case of deep vein thrombosis and pulmonary embolism. It is a choice for the obstetrics and it contains a lot of potential benefits and can be definitely used in a clinical practice to treat patients.it has its uses in children and pregnant women. Its use has brought about various advantages and hence can be employed in the clinical practice for the benefit of the people.
Keyword: Antithrombic agent ; unfractionated heparin ; obstetric ; deep vein thrombosis ; unstable angina ; pulmonary embolism
DOI: https://doi.org/10.31838/ijpr/2020.SP1.030
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free